NUVECTIS PHARMA INC. - COMMON STOCK

Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial Results and Business Highlights

22 Mar 2022 08:30:00 By Nasdaq GlobeNewswire

Update - Nuvectis Pharma to Participate in a Fireside Chat at the 34th Annual Roth Conference

09 Mar 2022 10:12:44 By Nasdaq GlobeNewswire

Nuvectis Announces Positive Data for NXP900 in Triple Negative Breast Cancer Preclinical Models with an Integrin-Linked Kinase (ILK) Loss

22 Feb 2022 08:30:00 By Nasdaq GlobeNewswire

Nuvectis Pharma Announces Closing of $16,000,000 Upsized Initial Public Offering of Common Stock

08 Feb 2022 13:00:00 By Nasdaq GlobeNewswire

Nuvectis Pharma, Inc. Announces Pricing of $16,000,000 Upsized Initial Public Offering of Common Stock

04 Feb 2022 09:30:32 By Nasdaq GlobeNewswire